Skip to Content

SZ 468 (Glimepiride and pioglitazone hydrochloride 2 mg / 30 mg (base))

Pill imprint SZ 468 has been identified as Glimepiride and pioglitazone hydrochloride 2 mg / 30 mg (base).

Glimepiride/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/pioglitazone 2 mg / 30 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Glimepiride and pioglitazone hydrochloride
SZ 468
2 mg / 30 mg (base)
Elliptical / Oval
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Sandoz Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.